Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for anaemia in non-dialysis chronic kidney disease
ACTRN12612001018808Phase 4Completed
- Sponsor
- Professor John OLYNYK FRACP MD
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Uraemic Anaemia comparing Pentoxifylline with Placebo (2 arms). Primary endpoints: Haemoglobin and Need to start erythropoiesis stimulating agent or iron therapy. Started Oct 2011; status: completed.
02
Drugs
pentoxifylline
03
Conditions
Uraemic Anaemia
Beyond the preview
Go deeper on ACTRN12612001018808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612001018808.